WebMar 5, 2024 · But investors buying CSL today can reasonably expect 12%-18% growth and 18x-21.5x earnings… with a five-year consensus return potential range of 9%-16% CAGR. Web14 hours ago · An investor buying $6,000 worth of CSL shares in April 2024 likely would have walked away with 37 stocks – paying $159.88 apiece – and approximately $85 …
3 Reasons Carlisle Is A Great Dividend Aristocrat - SeekingAlpha
Web1 day ago · The second segment, CSL Seqirus (19% of FY22 revenue), was acquired by CSL in 2015 and is the second-largest influenza business in the world. Although CSL … WebCarlisle Companies Incorporated (NYSE:CSL) today announced its second quarter 2024 financial results. Reported consolidated second quarter revenue of $1.2 billion, up 22% from second quarter 2024 Delivered second quarter diluted EPS of $1.77; adjusted diluted EPS of $2.16 Repurchased 643 thousand shares for $116 million, 1.6 million shares for $266 … hilary kinnear
Full Year Results 2024 - csl.com
WebFeb 16, 2024 · Investors pushed CSL shares up 8.5 per cent to $263.69 – adding almost $10 billion to the company’s market capitalisation in a day. However, the stock is still down more than 10 per cent for ... WebCSL's Investor Relations Center. Here you will find information relating to Financial Results, Financial Calendar, Annual Reports and other Shareholder-related information. We focus … CSL's Investor Relations Center. Here you will find information relating to Financial … CSL's latest and archived ASX Announcements We focus on rare and … Clinical trials cannot be done without the people who choose to participate. Some … CSL's clinical trials are one of the most important steps in the years-long … Investment in R&D is an important driver for CSL’s future growth. New and exciting … CSL is a global leader in developing and delivering high quality medicines that … CSL Limited's contact information including; CSL Worldwide locations, addresses, … KCENTRA®, our peri-operative bleeding product, grew 18% as hospital demand … Investors Careers Careers See Yourself at CSL Diversity & Inclusion How We Care … The CSL share registry is managed and maintained by Computershare. … WebOur Focus on Serious & Rare Diseases. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency. Read More. small wrought iron towel ring